Suppr超能文献

肥胖患者心血管评估与管理中的挑战:美国心脏病学会杂志前沿综述

Challenges in Cardiovascular Evaluation and Management of Obese Patients: JACC State-of-the-Art Review.

作者信息

Bianchettin Rosana G, Lavie Carl J, Lopez-Jimenez Francisco

机构信息

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.

John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana, USA.

出版信息

J Am Coll Cardiol. 2023 Feb 7;81(5):490-504. doi: 10.1016/j.jacc.2022.11.031.

Abstract

Many unique clinical challenges accompany the diagnosis and treatment of cardiovascular disease (CVD) in people living with overweight/obesity. Similarly, physicians encounter numerous complicating factors when managing obesity among people with CVD. Diagnostic accuracy in CVD medicine can be hampered by the presence of obesity, and pharmacological treatments or cardiac procedures require careful adjustment to optimize efficacy. The obesity paradox concept remains a source of confusion within the clinical community that may cause important risk factors to go unaddressed, and body mass index is a misleading measure that cannot account for body composition (eg, lean mass). Lifestyle modifications that support weight loss require long-term commitment, but cardiac rehabilitation programs represent a potential opportunity for structured interventions, and bariatric surgery may reduce CVD risk factors in obesity and CVD. This review examines the key issues and considerations for physicians involved in the management of concurrent obesity and CVD.

摘要

超重/肥胖人群心血管疾病(CVD)的诊断和治疗面临许多独特的临床挑战。同样,医生在管理CVD患者的肥胖问题时也会遇到众多复杂因素。肥胖的存在可能会妨碍CVD医学的诊断准确性,药物治疗或心脏手术需要仔细调整以优化疗效。肥胖悖论概念在临床界仍然是一个令人困惑的问题,可能导致重要风险因素未得到解决,而且体重指数是一种误导性指标,无法反映身体成分(如瘦体重)。支持减肥的生活方式改变需要长期坚持,但心脏康复计划是进行结构化干预的潜在机会,而减肥手术可能会降低肥胖和CVD患者的CVD风险因素。本综述探讨了参与同时管理肥胖和CVD的医生的关键问题和注意事项。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验